Channel Development &Commercialization
For projects with an established foundation that require channel
expansion, key account development, or commercialization support, we
help advance collaboration and market execution.
For projects with an established foundation that require channel
expansion, key account development, or commercialization support, we
help advance collaboration and market execution.
Where the goal goes beyond a single transaction and toward longer-term
collaboration, platform alignment, or resource integration, we support
deeper partnership design and execution.
Built on our long-standing experience in medical consumables and supply chain
execution, we support clinically relevant and cost-advantaged products in cross-border
market entry, supply chain coordination, channel collaboration, and commercialization,
including disposable endoscopy-related and other clinical products.
For mature medical devices, AI-assisted products, and specialty equipment that have
already obtained U.S. market clearance, we support channel expansion, key account
development, market education, and commercialization execution to help products
achieve more efficient market adoption.
Leveraging the combined strengths of advanced manufacturing in China in quality,
efficiency, and cost, we support overseas technologies, products, and brands in
connecting with Chinese manufacturing and industrialization resources, enabling
ODM / OEM, joint development, production execution, supply chain coordination, and
cross-border commercialization.
We help advanced imaging and frontier research equipment with strong technical
value and cost advantages enter U.S. research settings, combining expert collaboration
between the U.S. and China, joint research, publication support, and grant development
to build pathways from research collaboration toward clinical translation.
Centered on U.S. clinical data collaboration, real-world evidence, and data-driven
research support, we help relevant technologies, AI systems, medical devices,
and innovative programs explore more evidence-grounded pathways for research
validation, market entry, and commercialization. For opportunities that require a
better understanding of the U.S. clinical data environment, research feasibility,
and evidence-generation logic, .we can work with leading U.S. clinical data platform
partners and resources to support more practical pathway design and coordinated
execution.
If cross-border collaboration in healthcare is reduced to simply “selling a product into another country,”
the complexity of the work is immediately underestimated. What determines whether cooperation actually
happens is usually not the product alone, but whether the product, technology, or opportunity can find …
Many Chinese advanced equipment teams looking at the U.S. market fall into the same assumption: if the technology is leading, the cost structure is better, and the product is new enough, then the next
step should be direct clinical commercialization. It sounds intuitive, but in the U.S. healthcare system…
“We have resources.” That is probably one of the most common statements in cross-border collaboration.
The problem is that in healthcare, many real opportunities are not made successful by “having resources”
alone. The hardest part is rarely meeting a person, reaching an institution, or arranging a meeting. The …